Registration is now open for Targeting the CNS, the 14^th annual symposium of the Center for Targeted Therapeutics and Translational Nanomedicine (CT3N). The 2025 CT3N Symposium takes place on December 3 and will feature outstanding speakers from the fields of targeted therapeutics, drug delivery, biomaterials, and nanomedicine, with a focus on targeting the CNS. The symposium can be attended in person (in the Arthur H. Rubenstein Auditorium of the Smilow Center for Translational Research) or via a live webcast.

Keynote speakers include Polina Anikeeva, the Matoula S. Salapatas Professor of Materials Science and Engineering and a professor of brain and cognitive sciences at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology; and Viviana Gradinaru, the Troendle Professor of Neuroscience and Biological Engineering and director and Davis Leadership Chair of the Merkin Institute for Translational Research at California Institute of Technology. Further information about speakers and the symposium agenda and a link to register may be found at https://www.itmat.upenn.edu/ct3n/symposium/.